About Fluidda
Fluidda is the world leader in Functional Respiratory Imaging (FRI), a pioneering technology that combines high-resolution CT scans with Computational Fluid Dynamics (CFD) and artificial intelligence to revolutionize respiratory healthcare. Founded in 2005 and headquartered in Kontich, Belgium, Fluidda applies advanced engineering tools originally developed for aerospace applications to improve the diagnosis, monitoring, and treatment of respiratory diseases. The company operates as both a Contract Research Organization (CRO) providing services to pharmaceutical and biotech companies, and as a partner to healthcare professionals offering clinical decision support. Fluidda's FRI technology enables patient-specific analysis of lung structure and function, providing regional information that traditional lung function tests cannot capture. This approach makes clinical trials shorter, faster, and more cost-effective while enabling personalized medicine through optimized diagnosis and treatment monitoring. Fluidda's proprietary technology platform includes advanced algorithms for measuring blood vessel wall thickness, airway geometry, airflow distribution, and vascular density from standard CT scans. The company's Broncholab product assists radiologists and pulmonologists with treatment optimization for respiratory patients. In November 2025, Fluidda was acquired by Banook, a global leader in clinical trial services, strengthening its position in respiratory clinical research. Fluidda serves customers across pharmaceutical companies, medical device manufacturers, healthcare systems, and research institutions worldwide, with offices in Belgium, the United States (New York and Los Angeles), and Portugal (Lisbon).
Mission & Story
Mission
Our mission is to optimize treatment pathways, reduce healthcare costs and to limit the go-to-market time of respiratory drugs, pulmonology medical devices and therapies.
Founding Story
Fluidda was founded in 2005, focusing on applying Computational Fluid Dynamics (CFD), a discipline originally used in the design of aircraft wings, to respiratory medicine. The founders combined image processing of CT scans with flow simulations on patient-specific 3D models to create a unique tool for phenotyping patients and monitoring the efficacy of novel respiratory drugs.
Clinical Focus
Medical conditions and clinical areas addressed by Fluidda.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired by Banook in November 2025 to strengthen global leadership in respiratory clinical trial services. Broncholab regulatory approval extended in UK through 2024. Exclusive collaboration with Aptar Pharma announced September 2022. Multiple research publications and conference presentations at ERS2022 and RSNA 2022.
Awards & Recognition
Recognized as world leader in Functional Respiratory Imaging
Key Partnerships
Social & Media
Follow on
Latest Updates
FRI Research – Effect of posture on airflow distribution, airway geometry and air velocity
BANOOK ACQUIRES FLUIDDA, STRENGTHENING ITS GLOBAL LEADERSHIP IN RESPIRATORY CLINICAL TRIALSERVICES
FRI ANALYST (Portugal)
Towards the adoption of quantitative computed tomography in the management of interstitial lung disease
FRI technology showed substantial and homogeneous vasodilation during phase one research for new PAH medication.
Company Details
- Founded
- 2005
- Headquarters
- Kontich, Antwerp, Belgium
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSimilar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.